metricas
covid
Buscar en
Enfermedades Infecciosas y Microbiología Clínica (English Edition)
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica (English Edition) Role of Staphylococcus caprae in nosocomial infection
Información de la revista
Vol. 38. Núm. 9.
Páginas 455-456 (noviembre 2020)
Vol. 38. Núm. 9.
Páginas 455-456 (noviembre 2020)
Scientific letter
Acceso a texto completo
Role of Staphylococcus caprae in nosocomial infection
Papel del Staphylococcus caprae en la infección nosocomial
Visitas
4865
Laura Rodríguez Fernández
Autor para correspondencia
laurarofer3@gmail.com

Corresponding author.
, Javier Miguel Martín Guerra, Carlos Jesús Dueñas Gutiérrez
Servicio de Medicina Interna, Hospital Clínico Universitario de Valladolid, Spain
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Tablas (1)
Table 1. Characteristics of the series.
Texto completo

Staphylococcus caprae (S. caprae) is a gram-positive coagulase-negative, catalase-positive coccus, which was first described in 1958 as a skin and mammary glands coloniser in goats.1 It is considered a saprophytic flora that usually resides on the skin, nails and nasal mucosa.2 However, since the first case was described in 1983, its pathogenic role has been considered the cause of infections in different locations —peritonitis, meningitis, urinary tract infections, endocarditis, endophthalmitis, prosthetic joint infections, recurrent sepsis, bacteraemia, and osteomyelitis—. Risk factors include immunosuppressed states, obesity, traumatic or open fractures and especially contact with sheep or goats.3

As far as we can tell, the vast majority of cases are infections that settle on orthopaedic devices. The nosocomial origin of the infection, although difficult to prove, has been described within neonatal intensive care units, central line associated bacteraemia and after orthopaedic surgery.

Molecular techniques and matrix assisted laser desorption ionisation-time of flight mass spectrometry (MALDI-TOF MS) have led to an improvement in the identification of clinically relevant strains of S. caprae.4

In the last 10 years we have had the opportunity to attend to 13 cases of infections due to S. caprae (Table 1). Their mean age was 69 years (SD 12.9) with a clear male predominance (91%).

Table 1.

Characteristics of the series.

Case  Age/sex  Predisposing factor  Clinical picture  Prosthetic material involvement  Location  Culture  Accompanying polymicrobial/germ infection 
73/M  No  Multiple trauma  Yes  Cervical spine  Superficial tissue surgical wound exudate  No 
63/V  Pharmacological immunosuppression  Abscess  No  Thigh  Skin abscess exudate  Yes/Streptococcus oralis 
57/V  Diabetes mellitus  Diabetic foot  No  Foot  Deep tissue ulcer exudate  Yes/Actinomyces turicensis, Peptoniphilus, Parvimonas micra 
87/V  No  Aneurysm  No  Thigh  Superficial surgical wound exudate  No 
89/V  Diabetes mellitus, Chronic kidney disease  Diabetic foot  No  Foot  Deep tissue ulcer exudate  No 
61/V  No  Osteomyelitis  Yes  Leg  Deep tissue periosteal surgical wound exudate  Yes/Staphylococcus epidermidis 
66/V  No  Osteomyelitis  Yes  Foot  Deep tissue periosteal surgical wound exudate  No 
57/V  No  Pericardial effusion  No  Bacteriaemia  Blood  No 
88/V  No  Osteomyelitis  Yes  Foot  Deep tissue periosteal surgical wound exudate  Yes/Methicillin resistant Staphylococcus aureus, Staphylococcus epidermidis 
10  77/V  Diabetes mellitus, Pharmacological immunosuppression Chronic kidney disease  Arthritis  No  Foot  Joint fluid  Yes/Staphylococcus epidermidis 
11  63/V  No  Lower limb ischaemia  No  Leg  Superficial tissue surgical wound exudate  No 
12  62/V  Chronic kidney disease  Ischaemic heart disease  No  Bacteriaemia  Blood  Yes/Staphylococcus hominis 
13  53/V  Diabetes mellitus  Diabetic foot  No  Foot  Deep tissue ulcer exudate  Yes/ Staphylococcus capitis, Peptoniphilus harei, Fusobacterium gonidiaformans, Peptostreptococcus anaerobius 

The most common location was in the lower limbs (77%), followed by central line catheter associated bacteraemia (15%) and vertebral involvement (8%). Bone and/or joint involvement was observed in 54% with orthopaedic prosthetic material involvement of 31%, finally resolving in all cases.

At diagnosis, 46% had immunosuppressed states, and of all of those 67% had type 2 diabetes mellitus, 50% chronic kidney disease and 33% pharmacological immunosuppression secondary to corticosteroid consumption. The Charlson Index was greater than 5 points in 61% of cases.

In 54% of the cases the infection turned out to be polymicrobial with a predominance of association with cocci and gram-positive bacilli, while in the remaining 46% it was monomicrobial. Regarding antibiotic sensitivity only 8% showed resistance to fluoroquinolones and 23% to penicillins. Patients were mainly treated with beta-lactams (46%) and fluoroquinolones(31%); to a lesser extent, the use of glycopeptides (8%) and oxazolidinones (15%) was observed. Antibiotics were maintained for a mean of 29 days, excluding the case of joint involvement due to transfer of the patient to the reference centre. In 31% of the patients sequential therapy was possible, thus making treatment on an outpatient basis possible. In 92% of cases it presented as a nosocomial infection. No case of death was documented during the infectious process or 30 days after medical discharge.

S. caprae has been described as a potential pathogen with special voracity for orthopaedic devices in immunocompromised hosts.4 However, in our series we did not observe differences regarding the immunosuppression status, and in just 31% of cases did the infection involve orthopaedic prosthetic material. An association was observed in patients with greater comorbidity, but despite this, its mortality was low, which suggests low aggressiveness as a pathogen. Like other microorganisms in the coagulase-negative group,5S. caprae is mainly related to bone, joint and bacteraemia involvement. In summary, S. caprae is a primarily hospital-acquired microorganism whose pathogenic potential is currently underestimated, so knowledge and early detection would help to control this emerging pathogen.

References
[1]
L.A. Devriese, B. Poutrel, R. Kilpper-Balz, K.H. Schleifer.
Staphylococcus gallinarum and Staphylococcus caprae, two new species from animals.
Int J Syst Bacteriol, 33 (1983), pp. 480-486
[2]
A. Gowda, A.L. Pensiero, C.D. Packer.
Staphylococcus caprae: A Skin Commensal with Pathogenic Potential.
Cureus, 10 (2018), pp. e3485
[3]
C. Hilliard, J. El Masri, M. Goto.
Staphylococcus caprae bacteraemia and native bone infection complicated by therapeutic failure and elevated MIC: a case report.
JMM Case Reports., 4 (2017),
[4]
P. Seng, M. Barbe, P. Pinelli, F. Gouriet, M. Drancourt, A. Minebois, et al.
Staphylococcus caprae bone and joint infections: a re-emerging infection?.
Clinical Microbiology and Infection., 20 (2014), pp. O1052-O1058
[5]
K. Becker, C. Heilmann, G. Peters.
Coagulase-negative Staphylococci.
Clin Microbiol Rev., 27 (2014), pp. 870-926

Please cite this article as: Rodríguez Fernández L, Martín Guerra JM, Dueñas Gutiérrez CJ. Papel del Staphylococcus caprae en la infección nosocomial. Enferm Infecc Microbiol Clin. 2020;38:455–456.

Copyright © 2020. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos